05Jan 2023
Biomarker signature and pathophysiological pathways in chronic heart failure patients with metabolic syndrome

Biomarker signature and pathophysiological pathways in chronic heart failure patients with metabolic syndrome

The comorbidities that collectively define the metabolic syndrome are common in patients with heart failure. However, the role of metabolic syndrome in the pathophysiology of heart failure needs to be better understood. Therefore, the study investigated the clinical and biomarker correlates of metabolic syndrome in patients with heart failure. Metabolic syndrome is highly prevalent in heart failure and is associated with biomarkers and pathways relating to obesity, lipid metabolism, and the immune responses underlying chronic inflammation.

  • #cardiology

Like

Save

Share